Li S, Liu C, Weng L
Cancer Med. 2025; 14(2):e70620.
PMID: 39840708
PMC: 11751862.
DOI: 10.1002/cam4.70620.
James C, Lewis R, Witt A, Carter C, Rais N, Wang X
Tumour Virus Res. 2024; 19:200302.
PMID: 39667669
PMC: 11699615.
DOI: 10.1016/j.tvr.2024.200302.
James C, Lewis R, Witt A, Carter C, Rais N, Wang X
bioRxiv. 2024; .
PMID: 39345623
PMC: 11430071.
DOI: 10.1101/2024.09.16.613347.
Wan L, Chen K, Ma X, Han L, Xie Q, Wang L
Naunyn Schmiedebergs Arch Pharmacol. 2024; .
PMID: 39325153
DOI: 10.1007/s00210-024-03445-5.
Makioka D, Inada M, Awano M, Saito E, Shinoda T, Abe S
Microorganisms. 2024; 12(6).
PMID: 38930587
PMC: 11205804.
DOI: 10.3390/microorganisms12061205.
High rate of high-risk human papillomavirus among benign and breast cancer patients in Ethiopia.
Belachew E, Desta A, Mulu A, Deneke D, Tefera D, Alemu A
PLoS One. 2024; 19(3):e0298583.
PMID: 38507429
PMC: 10954173.
DOI: 10.1371/journal.pone.0298583.
Age at menopause is inversely related to the prevalence of common gynecologic cancers: a study based on NHANES.
Cheng G, Wang M, Sun H, Lai J, Feng Y, Liu H
Front Endocrinol (Lausanne). 2023; 14:1218045.
PMID: 38034008
PMC: 10687479.
DOI: 10.3389/fendo.2023.1218045.
Combined Inhibition of Indolamine-2,3-Dioxygenase 1 and C-X-C Chemokine Receptor Type 2 Exerts Antitumor Effects in a Preclinical Model of Cervical Cancer.
Lizcano-Meneses S, Hernandez-Pando R, Garcia-Aguirre I, Bonilla-Delgado J, Alvarado-Castro V, Cisneros B
Biomedicines. 2023; 11(8).
PMID: 37626777
PMC: 10452145.
DOI: 10.3390/biomedicines11082280.
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer.
Aghbash P, Hemmat N, Baradaran B, Mokhtarzadeh A, Poortahmasebi V, Oskuee M
Oncol Res. 2023; 30(3):99-116.
PMID: 37305016
PMC: 10208084.
DOI: 10.32604/or.2022.026776.
Investigation of the Antineoplastic Effects of 2-(4-Chlorophenyl)-13α-Estrone Sulfamate against the HPV16-Positive Human Invasive Cervical Carcinoma Cell Line SiHa.
Ali H, Traj P, Szebeni G, Gemes N, Resch V, Paragi G
Int J Mol Sci. 2023; 24(7).
PMID: 37047597
PMC: 10095317.
DOI: 10.3390/ijms24076625.
Coinfection of HPVs Is Associated with Advanced Stage in Colorectal Cancer Patients from Qatar.
Fernandes Q, Gupta I, Murshed K, Abo Samra H, Al-Thawadi H, Vranic S
Pathogens. 2023; 12(3).
PMID: 36986346
PMC: 10053117.
DOI: 10.3390/pathogens12030424.
Stress keratin 17 and estrogen support viral persistence and modulate the immune environment during cervicovaginal murine papillomavirus infection.
Wang W, Spurgeon M, Pope A, McGregor S, Ward-Shaw E, Gronski E
Proc Natl Acad Sci U S A. 2023; 120(12):e2214225120.
PMID: 36917668
PMC: 10041145.
DOI: 10.1073/pnas.2214225120.
Preclinical models in head and neck squamous cell carcinoma.
Chaves P, Garrido M, Oliver J, Perez-Ruiz E, Barragan I, Rueda-Dominguez A
Br J Cancer. 2023; 128(10):1819-1827.
PMID: 36765175
PMC: 10147614.
DOI: 10.1038/s41416-023-02186-1.
Transcriptomic analysis provides insight into the mechanism of IKKβ-mediated suppression of HPV18E6-induced cellular abnormalities.
Collins Q, Grunsted M, Arcila D, Xiong Y, Barmchi M
G3 (Bethesda). 2023; 13(4).
PMID: 36722216
PMC: 10085804.
DOI: 10.1093/g3journal/jkad020.
A Drosophila model of HPV16-induced cancer reveals conserved disease mechanism.
Hashemi L, Ormsbee M, Patel P, Nielson J, Ahlander J, Barmchi M
PLoS One. 2022; 17(12):e0278058.
PMID: 36508448
PMC: 9744332.
DOI: 10.1371/journal.pone.0278058.
Human Papillomaviruses-Related Cancers: An Update on the Presence and Prevention Strategies in the Middle East and North African Regions.
Fernandes Q, Allouch S, Gupta I, Elmakaty I, Elzawawi K, Amarah A
Pathogens. 2022; 11(11).
PMID: 36422631
PMC: 9692443.
DOI: 10.3390/pathogens11111380.
Human papillomavirus targets the YAP1-LATS2 feedback loop to drive cervical cancer development.
Huang C, Lv X, Chen P, Liu J, He C, Chen L
Oncogene. 2022; 41(30):3761-3777.
PMID: 35761037
PMC: 10399300.
DOI: 10.1038/s41388-022-02390-y.
Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer.
Lasche M, Gallwas J, Grundker C
Int J Mol Sci. 2022; 23(9).
PMID: 35563441
PMC: 9103757.
DOI: 10.3390/ijms23095050.
Two conserved amino acids differentiate the biology of high-risk and low-risk HPV E5 proteins.
Sudarshan S, Schlegel R, Liu X
J Med Virol. 2022; 94(9):4565-4575.
PMID: 35509176
PMC: 9283228.
DOI: 10.1002/jmv.27829.
AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.
Miller J, Dakic A, Spurgeon M, Saenz F, Kallakury B, Zhao B
J Med Virol. 2022; 94(8):3962-3977.
PMID: 35437795
PMC: 9199254.
DOI: 10.1002/jmv.27795.